The Most Respected Medical Journal In The U.S. Just Eviscerated A Drug That's Cost Taxpayers Over $1 Billion

Published: Sep 13, 2017

A new study published by JAMA Internal Medicine poses a really important question to lawmakers and taxpayers alike.

Over the past five years, why has the US government spent $1 billion on a drug that is no more effective than alternatives that are tens of thousands of dollars cheaper per treatment?

Back to news